Poland· PL-100328878
X-Systo
A pivmecillinam product containing pivmecillinami hydrochloridum, registered in Poland by Karo Pharma AB. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Pivmecillinam is registered in 12 of 19 countries.
Countries holding a registration under ATC J01CA08 (pivmecillinam), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Pivmecillinam · ATC J01CA08
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Pivmecillinami hydrochloridum
- Manufacturer
- Karo Pharma AB
- Country
- Poland (PL)
- ATC code
- J01CA08
- ATC class
- Pivmecillinam
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991211714
- gtin05909991211721
- gtin05909991211738
- gtin05909991386450
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pivmecillinam in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsSelexid 400 mg filmomhulde tablettenEureco-Pharma B.V.
- SpainSELEXID 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGKaro Pharma Ab
- IcelandSelexidKaro Pharma AB*
- NorwaySelexidKaro Pharma AB (1)
- United KingdomPivmecillinam 200mg tabletsMilpharm Ltd
- FinlandSelexidLeo Pharma A/S
- FranceSELEXID 200 mg, comprimé pelliculéKARO PHARMA (SUEDE)
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Portugal · Selexid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf3fae38-85be-48ba-9d74-7165c8d0c667 GET /v1/drugs/bf3fae38-85be-48ba-9d74-7165c8d0c667?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "400 mg",
"packaging": "05909991211714 ¦ Rp ¦ 107185\n10 tabl.\n05909991211721 ¦ Rp ¦ 107186\n15 tabl.\n05909991211738 ¦ Rp ¦ 107187\n20 tabl.\n05909991386450 ¦ Rp ¦ 130128\n9 tabl.",
"substance": "Pivmecilinami hydrochloridum 400 mg",
"common_name": "Pivmecillinami hydrochloridum",
"pl_product_id": "100328878",
"pozwolenie_nr": "22359",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about pivmecillinam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.